Turk Ilac Ve Serum Sanayi Anonim Sirketi (BIST: TRILC) Stock Analysis & Fundamentals

TRILCTurk Ilac Ve Serum Sanayi Anonim Sirketi

BIST · TR · Healthcare · Drug Manufacturers - Specialty & Generic · turkilac.com.tr

1.160TRY+0.87%Mkt Cap: 28.52M $P/E: —Today

Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap28.52M $

Enterprise Value126.03M $

Revenue (TTM)121.64M $

Gross Profit19.17M $

Net Income (TTM)1.73M $

Revenue/Share0.1173 USD

Last Price1.160 TRY

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees689

CountryTR

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA3.88

EV/Revenue1.04

P/S0.23

P/B0.60

EPS (TTM)-0.50

EPS (Forward)—

52W Range

1.1301% of range4.400

52W High4.400 TRY

52W Low1.130 TRY

Profitability

Gross Margin31.22%

Oper. Margin20.40%

EBITDA Margin26.71%

Profit Margin2.82%

ROE3.76%

ROA1.81%

Growth

Revenue Growth65.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF-9.05M $

CapEx (TTM)3.63M $

FCF Margin-58.73%

FCF Yield-250.49%

Net Debt97.52M $

Net Debt/EBITDA3.00

Balance Sheet

Debt/Equity0.86

Current Ratio0.99

Quick Ratio0.49

Book Value/Sh1.915 TRY

Cash/Share0.0440 TRY

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 TRY

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split640.8949:100

Split DateApr 27, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.04B

Float422.42M

Insiders26.76%

Institutions0.07%

Technical

SMA 501.254 (-7.5%)

SMA 2002.355 (-50.7%)

Beta0.21

S&P 52W Chg18.16%

Avg Vol (30d)6.98M

Avg Vol (10d)4.59M

Technical Indicators

RSI (14)37.4

MACD-0.0638

MACD Signal-0.0715

MACD Hist.+0.0078

BB Upper1.328 TRY

BB Middle1.214 TRY

BB Lower1.100 TRY

BB Width18.83%

ATR (14)0.0397 TRY

Vol Ratio (20d)0.92x